Sahajanand Medical Technologies IPO: Issue Details, OFS Structure and What Investors Should Know

IPO Issue Details

The company has priced its issue in the range of ₹327-₹344 per share with a lot size of 43 shares. At the upper end of the price band the minimum retail application amount would be ₹14,792. The issue has been raised through the book-building process and participation is available to eligible retail investors, non-institutional investors and qualified institutional buyers.

The issue was around 1.38 crore shares @ ₹344/- each (total value ₹475.48 Cr). The basis of allotment was expected on 21st Oct, the shares to be credited and refunds to be processed on 22nd Oct and the tentative listing date was 23rd Oct 2026. Investors are advised to check the exchange for any updates to the schedule.

Why the OFS Structure Matters

The IPO was purely an offer for sale (OFS) so it was existing shareholders selling their shares rather than the company issuing new shares to raise funds.

The proceeds from the offering go to the selling shareholders and Sahajanand Medical Technologies doesn't get any fresh funds from the IPO. That's a key difference as an OFS is very different to a fresh issue where the company would be in a position to use the proceeds for expansion, to pay down debt etc. etc.

What Should Investors Consider?

Sahajanand Medical Technologies is in the medical devices space (specifically devices used in cardiac procedures). Any investor looking at the company would be well advised to look at its financials, valuation, competitive position, the risks involved in the business and the rationale behind the existing shareholders who are selling their shares.

IPO demand or grey market premiums in themselves are not a good predictor of listing performance. You need to look at the company's offer documents and make your own decision based on your own investment objectives and your own level of risk tolerance.